Weill David
SEC Form 4 insider trading activity
Weill David has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Weill David is listed as Director at TransMedics Group, Inc. Inside the rolling window, Weill David reported 1 open-market purchase totaling $109K in TMDX and 2 open-market sales totaling $1.2M in TMDX. The largest disclosed transaction in the window is a sale of 5,000 TMDX shares on Dec 3, 2025, worth $693K.
Companies traded
Other insiders at TMDX
Insider Buying
$109K
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Weill David made?
Weill David has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Weill David trade?
Weill David has filed SEC Form 4 disclosures for 1 company, including TMDX.
When was Weill David's most recent SEC Form 4 filing?
Weill David's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Weill David's total buy and sell value in the current window?
Inside the rolling retention window, Weill David bought $109K and sold $1.2M based on SEC Form 4 filings.
What was Weill David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,000 TMDX shares on 2025-12-03, worth $693K, per SEC Form 4 filings.